{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:21:27Z","timestamp":1768566087172,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12906-016-1035-y","type":"journal-article","created":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T04:58:33Z","timestamp":1454734713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Emu oil offers protection in Crohn\u2019s disease model in rats"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2693-8596","authenticated-orcid":false,"given":"Bhaskar","family":"Vemu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Selvasubramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Pandiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,6]]},"reference":[{"key":"1035_CR1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","volume":"115","author":"C Fiocchi","year":"1998","unstructured":"Fiocchi C. Inflammatory Bowel Disease: etiology and pathogenesis. Gastroenterology. 1998;115:182\u2013205.","journal-title":"Gastroenterology"},{"key":"1035_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/DDDT.S11290","volume":"5","author":"KJ Triantafillidis","year":"2011","unstructured":"Triantafillidis KJ, Merikas E, Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Dev Ther. 2011;5:185\u2013210.","journal-title":"Drug Des Dev Ther"},{"key":"1035_CR3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3923\/rjmp.2010.141.148","volume":"4","author":"CD Deshmukh","year":"2010","unstructured":"Deshmukh CD, Pawar AT, Bantal V. Effect of Embilica officinalis methanolic fruit extract on indomethacin induced enterocolitis in rats. Res J Med Plant. 2010;4:141\u20138.","journal-title":"Res J Med Plant"},{"key":"1035_CR4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.phymed.2009.10.013","volume":"17","author":"S Krebs","year":"2010","unstructured":"Krebs S, Omer TN, Omer B. Wormwood (Artemisia absinthium) suppresses tumor necrosis factor alpha and accelerates healing in patients with Crohn\u2019s disease \u2013 A controlled clinical trial. Phytomedicine. 2010;17:305\u20139.","journal-title":"Phytomedicine"},{"key":"1035_CR5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S0007114511000390","volume":"106","author":"Q Jia","year":"2011","unstructured":"Jia Q, Ivanov I, Zlatev ZZ, Alaniz RC, Weeks BR, Callaway ES, et al. Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphate treated mice. Br J Nutr. 2011;106:519\u201329.","journal-title":"Br J Nutr"},{"key":"1035_CR6","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jnutbio.2011.05.003","volume":"23","author":"AP Neilson","year":"2012","unstructured":"Neilson AP, Djuric Z, Ren J, Hong YH, Sen A, Lager C, et al. Effect of cyclooxygenase genotype and dietary fish oil on colonic eicosanoids in mice. J Nutr Biochem. 2012;23:966\u201376.","journal-title":"J Nutr Biochem"},{"issue":"36","key":"1035_CR7","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.3748\/wjg.v16.i36.4504","volume":"16","author":"R Rahimi","year":"2010","unstructured":"Rahimi R, Ardekani MRS, Abdollahi M. A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. World J Gastroenterol. 2010;16(36):4504\u201314.","journal-title":"World J Gastroenterol"},{"key":"1035_CR8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.lfs.2011.01.010","volume":"88","author":"MY Park","year":"2011","unstructured":"Park MY, Kwon HJ, Sung MK. Dietary aloin, aloesin, or aloe-gel exerts anti-inflammatory activity in a rat colitis model. Life Sci. 2011;88:486\u201392.","journal-title":"Life Sci"},{"key":"1035_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-998-0001-9","volume":"6","author":"MW Whitehouse","year":"1998","unstructured":"Whitehouse MW, Turner AG, Davis CKC, Roberts MS. Emu Oil(s): a source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine. Inflammopharmacology. 1998;6:1\u20137.","journal-title":"Inflammopharmacology"},{"key":"1035_CR10","doi-asserted-by":"crossref","unstructured":"Vemu B, Selvasubramanian S, Pandiyan V. Anti-inflammatory activity of emu oil in indomethacin induced inflammatory bowel disease in rats. Proc Indian Natl Sci Acad B Biol Sci. 2015; doi: 10.1007\/s40011-015-0564-3 .","DOI":"10.1007\/s40011-015-0564-3"},{"issue":"5","key":"1035_CR11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/0253-7613.44152","volume":"40","author":"S Khare","year":"2008","unstructured":"Khare S, Asad M, Dhamanigi SS, Satya PV. Antiulcer activity of cod liver oil in rats. Ind J Pharmacol. 2008;40(5):209\u201314.","journal-title":"Ind J Pharmacol"},{"key":"1035_CR12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11745-003-1104-y","volume":"38","author":"S Yoganathan","year":"2003","unstructured":"Yoganathan S, Nicolosi R, Wilson T. Antagonism of croton oil inflammation by topical emu oil in CD-1 mice. Lipids. 2003;38:603\u20137.","journal-title":"Lipids"},{"key":"1035_CR13","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/j.burns.2006.10.346","volume":"33","author":"C Lagniel","year":"2007","unstructured":"Lagniel C, Torres AM. Consequences of burn injuries treatment with 100\u00a0% pure emu oil. Burns. 2007;33:S148.","journal-title":"Burns"},{"key":"1035_CR14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nutres.2003.12.004","volume":"24","author":"AT Wilson","year":"2004","unstructured":"Wilson AT, Nicolosi RJ, Handelman G, Yoganathan S, Kotyla T, Orthoefer F, et al. Comparative effects of emu and olive oil on aortic early atherosclerosis and associated risk factors in hypercholesterolemic hamsters. Nutr Res. 2004;24:395\u2013406.","journal-title":"Nutr Res"},{"key":"1035_CR15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10620-011-1979-1","volume":"57","author":"SM Abimosleh","year":"2011","unstructured":"Abimosleh SM, Lindsay RJ, Butler RN, Cummins AG, Howarth GS. Emu oil increases colonic crypt depth in a rat model of ulcerative colitis. Dig Dis Sci. 2011;57:887\u201396.","journal-title":"Dig Dis Sci"},{"key":"1035_CR16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1440-1746.2012.07098.x","volume":"27","author":"SM Abimosleh","year":"2012","unstructured":"Abimosleh SM, Tran CD, Howarth GS. Emu Oil: a novel therapeutic for disorders of the gastrointestinal tract? J Gastroenterol Hepatol. 2012;27:857\u201361.","journal-title":"J Gastroenterol Hepatol"},{"key":"1035_CR17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00054725-199503000-00007","volume":"1","author":"RB Sartor","year":"1995","unstructured":"Sartor RB. Insights into the pathogenesis of inflammatory bowel diseases provided by New Rodent Models of spontaneous colitis. Inflamm Bowel Dis. 1995;1:64\u201375.","journal-title":"Inflamm Bowel Dis"},{"key":"1035_CR18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/BF00920471","volume":"17","author":"T Yamada","year":"1993","unstructured":"Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation. 1993;17:641\u201362.","journal-title":"Inflammation"},{"key":"1035_CR19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2036.2000.00694.x","volume":"14","author":"A Anthony","year":"2000","unstructured":"Anthony A, Pounder RE, Dhillon AP, Wakefield AJ. the inflammatory bowel disease study group. Similarities between ileal Crohn\u2019s disease and indomethacin experimental jejunal ulcers in the rat. Aliment Pharmacol Therapeut. 2000;14:241\u20135.","journal-title":"Aliment Pharmacol Therapeut"},{"key":"1035_CR20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00054725-200411000-00009","volume":"10","author":"GF Bonner","year":"2004","unstructured":"Bonner GF, Fakhri A, Vennamaneni SR. A long term cohort study of non steroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:751\u20137.","journal-title":"Inflamm Bowel Dis"},{"key":"1035_CR21","doi-asserted-by":"crossref","unstructured":"Langmead L, Feakins RM, Goldthorpe S, Holt H, Tsironi E, De Silva A, et al. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Therapeut. 2004b;19:739-47.","DOI":"10.1111\/j.1365-2036.2004.01902.x"},{"key":"1035_CR22","first-page":"343","volume":"49","author":"SS Shirke","year":"2011","unstructured":"Shirke SS. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases, M. Pharm. Thesis, Mumbai University, Mumbai, 2002. In: Jagtap AG, Niphadkar PV. Protective effect of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice. Indian J Exp Biol. 2011;49:343\u201351.","journal-title":"Indian J Exp Biol"},{"key":"1035_CR23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0006-2944(76)90049-1","volume":"15","author":"K Yagi","year":"1976","unstructured":"Yagi K. Simple fluorimetric assay for lipid peroxides in blood plasma. Biochem Med. 1976;15:212\u20136.","journal-title":"Biochem Med"},{"key":"1035_CR24","first-page":"196","volume-title":"Handbook of Oxygen Radical Research","author":"AL Caliborne","year":"1985","unstructured":"Caliborne AL. Assay of catalase. In: Greenwald RA, editor. Handbook of Oxygen Radical Research. Florida: CRC Press; 1985. p. 196\u2013201."},{"key":"1035_CR25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"SL Marklund","year":"1974","unstructured":"Marklund SL, Marklund G. Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47:474\u201396.","journal-title":"Eur J Biochem"},{"key":"1035_CR26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1126\/science.179.4073.588","volume":"179","author":"JD Rotruck","year":"1973","unstructured":"Rotruck JD, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium, biochemical role as a component of glutathione peroxidase and assay. Science. 1973;179:588\u201390.","journal-title":"Science"},{"key":"1035_CR27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Meron","year":"1979","unstructured":"Meron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione-s-transferase activities in rat lung and liver. Biochim Biophys Acta. 1979;582:67\u201378.","journal-title":"Biochim Biophys Acta"},{"key":"1035_CR28","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0016-5085(84)90202-6","volume":"87","author":"JE Krawisz","year":"1986","unstructured":"Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology. 1986;87:1344\u201350.","journal-title":"Gastroenterology"},{"key":"1035_CR29","first-page":"43","volume":"4","author":"NL Ashtaral","year":"2006","unstructured":"Ashtaral NL, Mohammadirad A, Yasa N, Minaie B, Nikfar S, Ghazanfari G, et al. Benefits of Zataria multiflora Boiss in experimental model of mouse inflammatory bowel disease. eCAM. 2006;4:43\u201350.","journal-title":"eCAM"},{"key":"1035_CR30","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00228-009-0719-3","volume":"65","author":"H Kelfalakes","year":"2009","unstructured":"Kelfalakes H, Stylianides TJ, Amanakis G, Kolios G. Exacerbation of inflammatory bowel diseases associated with the use of non-steroidal anti-inflammatory drugs: myth or reality? Eur J Clin Pharmacol. 2009;65:963\u201370.","journal-title":"Eur J Clin Pharmacol"},{"key":"1035_CR31","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0016-5085(00)70371-4","volume":"118","author":"JM Barrios","year":"2000","unstructured":"Barrios JM, Litchinberger LM. Role of Biliary phosphatidyl choline in bile acid protection and NSAID injury of the ileal mucosa in rats. Gastroenterology. 2000;118:1179\u201386.","journal-title":"Gastroenterology"},{"key":"1035_CR32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm0295-154","volume":"1","author":"LM Lichtenberger","year":"1995","unstructured":"Lichtenberger LM, Wang ZM, Romero JJ, Ulloa C, Perez JC, Giraud MN, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID induced gastrointestinal injury. Nat Med. 1995;1:154\u20138.","journal-title":"Nat Med"},{"key":"1035_CR33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gut.41.3.344","volume":"41","author":"S Somasundaram","year":"1997","unstructured":"Somasundaram S, Rafi S, Hayllar J, Sigthorsson G, Jacob M, Price AB, et al. Mitochondrial damage: a possible mechanism of the \u201ctopical\u201d phase of NSAID induced injury to the rat intestine. Gut. 1997;41:344\u201353.","journal-title":"Gut"},{"key":"1035_CR34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.clinbiochem.2007.01.015","volume":"40","author":"M Petruzzelli","year":"2007","unstructured":"Petruzzelli M, Vacca M, Moschetta A, Cinzia SR, Palasciano G, van Erpecum KJ, et al. Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: Role of bile salts. Clin Biochem. 2007;40:503\u201310.","journal-title":"Clin Biochem"},{"key":"1035_CR35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2036.2000.00702.x","volume":"14","author":"D Kelly","year":"2000","unstructured":"Kelly D, Anthony A, Piasecki C, Lewin J, Pounder RE, Wakefield AJ. Endothelial changes precede mucosal ulceration induced by indomethacin: an experimental study in the rat. Aliment Pharmacol Therapeut. 2000;14:489\u201396.","journal-title":"Aliment Pharmacol Therapeut"},{"key":"1035_CR36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.etp.2006.06.004","volume":"58","author":"ZA Radi","year":"2006","unstructured":"Radi ZA, Khan NK. Effects of cyclooxygenase inhibition on the gastrointestinal tract. Exp Toxicol Pathol. 2006;58:163\u201373.","journal-title":"Exp Toxicol Pathol"},{"key":"1035_CR37","doi-asserted-by":"crossref","first-page":"G804","DOI":"10.1152\/ajpcell.1996.270.4.C1096","volume":"270","author":"T Yamada","year":"1996","unstructured":"Yamada T, Hoshino M, Hayakawa T, Kamiya Y, Ohhara H, Mizuno K, et al. Bile secretion in rats with indomethacin-induced intestinal inflammation. Am J Physiol. 1996;270:G804\u201312.","journal-title":"Am J Physiol"},{"key":"1035_CR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00054725-199606000-00011","volume":"2","author":"EM Conner","year":"1996","unstructured":"Conner EM, Brand SJ, Davis JM, Kang DY, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. Inflamm Bowel Dis. 1996;2:133\u201347.","journal-title":"Inflamm Bowel Dis"},{"key":"1035_CR39","first-page":"541","volume-title":"Inflammation: basic principles and clinical correlates","author":"SJ Klebanoff","year":"1992","unstructured":"Klebanoff SJ. Oxygen metabolites from phagocytes. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates. New York: Raven; 1992. p. 541\u201388."},{"key":"1035_CR40","doi-asserted-by":"crossref","unstructured":"Buffinton GD, Doe WF. Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients. Free Radic Biol Med. 1995a;22:131-43.","DOI":"10.3109\/10715769509147535"},{"key":"1035_CR41","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI992","volume":"101","author":"C Wahl","year":"1998","unstructured":"Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Investig. 1998;101:1163\u201374.","journal-title":"J Clin Investig"},{"key":"1035_CR42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.freeradbiomed.2009.11.014","volume":"48","author":"S Borniquel","year":"2010","unstructured":"Borniquel S, Jansson EA, Cole MP, Freeman BA, Lundberg JO. Nitrated oleic acid up-regulates PPAR\u03b3 and attenuates experimental inflammatory bowel disease. Free Radic Biol Med. 2010;48:499\u2013505.","journal-title":"Free Radic Biol Med"},{"key":"1035_CR43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3565(24)35266-8","volume":"292","author":"JY Ro","year":"2000","unstructured":"Ro JY, Lee B, Kim JY, Chung Y, Chung MH, Lee SK. Inhibitory mechanism of aloe single component (Alprogen) on mediator release in guinea pig lung mast cells activated with specific antigen-antibody reactions. J Pharmacol Exp Therapeut. 2000;292:114\u201321.","journal-title":"J Pharmacol Exp Therapeut"},{"key":"1035_CR44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/0019-5154.44785","volume":"53","author":"A Surjushe","year":"2008","unstructured":"Surjushe A, Vasani R, Saple DG. Aloe Vera: a short review. Indian J Dermatol. 2008;53:163\u201366.","journal-title":"Indian J Dermatol"},{"key":"1035_CR45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","volume":"201","author":"M Arita","year":"2005","unstructured":"Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, et al. Stereochemical assignment, anti-inflammatory properties and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med. 2005;201:713\u201322.","journal-title":"J Exp Med"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-016-1035-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T09:44:14Z","timestamp":1748771054000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-016-1035-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1186\/s12906-016-1035-y","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"55"}}